P&R brief Spain: Funding and healthcare trends

Significant changes are on the horizon for Spain’s healthcare sector, encompassing funding trends and regulatory updates. Find out how pharmaceutical funding decisions are changing, the recent patterns in funding approvals, and what proactive steps manufacturers can take to navigate these shifts effectively.  

In the near term, the access of medicines and health products in Spain may witness notable shifts, marked by evolving funding trends and regulatory changes. This article aims to explore emerging funding patterns and ongoing updates to policies in Spain impacting drug evaluation and funding.

How have funding trends for drugs evolved in recent years?

At Simon-Kucher, we have studied and analyzed national funding resolutions for new innovative drugs entering the market and existing drugs expanding therapeutic indications. Our research looks at the pricing and reimbursement (P&R) conditions accompanying these funding…